Down We Go?
Yesterday, we discussed how the market had shown relative strength recently and asked the question whether the bullish sentiment would last. While it’s hard to know precisely when a bottom will take place, we highlighted the danger of trying to pick the low point because inevitably at some stage betting on the bottom will lead to a losing trade where lower lows follow. » Read more about: Down We Go? »
Read More
Will Oligarchs Buy Bitcoin?
Money and banking have been a major topic of concern since the most recent conflict, and the invasion of Ukraine began on February 24, 2022. Even before the military invasion, Ukraine was one of the largest crypto adopters in the world, along with Russia and Venezuela. As the world looks to isolate Russia with sanctions,
» Read more about: Will Oligarchs Buy Bitcoin? »
Read More
2 Stocks To 2x Your Money
Historically, dividend stocks have been a great way to create wealth, yielding higher returns and lower volatility, on average, than companies that do not pay dividends.
Over time, dividend income increases can be enormously profitable. Take Warren Buffett’s investment in Coca Cola as an example. When factoring in dividend increases and stock splits,
» Read more about: 2 Stocks To 2x Your Money »
Read More
Russian Ruble Crashes, The BIG Winner Is…
The international response to the Russian invasion of Ukraine has been rapid and stern. In addition to individual sanctions placed on Putin and much of his cabinet, the Russian banking system has been crippled by having its assets frozen and exclusion from the SWIFT network relied on by international banks for secure data transmission. The effects could be wide-ranging and have repercussions far into the future.
» Read more about: Russian Ruble Crashes, The BIG Winner Is… »
Read More
Is This Little-Known Health Innovation The Next Big Thing?
It’s hard to find the next big thing but Exact Sciences might be as close as any company is to it via its liquid biopsies, a transformative approach to diagnosing and monitoring various diseases by detecting signs of cancer, genetic anomalies, or other conditions in blood or other bodily fluids.
This technology has been particularly promising for cancer,
» Read more about: Is This Little-Known Health Innovation The Next Big Thing? »
Read MoreThe Burst
Market Commentary: $25 Billion Stock On Sale 90% Lower?
One of Warren Buffett’s old favorites, Brazil’s StoneCo, has emerged with a strategy that may create a U-turn in it share price. What was once a $25 billion company has crashed to just $3 billion and change in market capitalization.
Yet StoneCo hasn’t been knocked out for the count yet. It surprised investors with an announcement that signaled it was bullish on its own company via a R$300 million (approximately $58.2 million) share repurchase program.
» Read more about: Market Commentary: $25 Billion Stock On Sale 90% Lower? »
Read MoreThe Spotlight
1 Stock To Buy If Mobile Ad Spending Explodes
Mobile apps have become a massive business opportunity. There are nearly 900,000 app publishers worldwide, with more than 41,000 in the United States. Some of the biggest names include Roblox, Oppana Games, Innersloth, and Play365. However, many app publishers are small companies with just a few developers on staff.
Of the 2.75 million apps on the market,
» Read more about: 1 Stock To Buy If Mobile Ad Spending Explodes »
Read MoreThe Daily
1 Dividend Powerhouse Built for the Long Haul
When investors talk about reliability in the energy sector, Enbridge (NYSE: ENB) belongs in a class of its own. For over seven decades, this Canadian pipeline and utility powerhouse has paid a dividend, an almost unheard-of feat in an industry known for boom-and-bust cycles.
Even more impressive is that it has raised its dividend for 30 consecutive years,
» Read more about: 1 Dividend Powerhouse Built for the Long Haul »